• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Staphylococcus aureus causes various infections, including skin and soft tissue infections
and pneumonia via both, community-associated and nosocomial infection. These infectious …

Background: Streptococci frequently cause infective endocarditis (IE), yet the prevalence of
IE in patients with bloodstream infections (BSIs) caused by different streptococcal species is …

Abstract Objectives Patients with Staphylococcus aureus bacteraemia (SAB) at risk for
infective endocarditis (IE) need to be identified because they should undergo …

Background Staphylococcus aureus bacteremia (SAB) is a heterogeneous disease with
changing epidemiology due to changing demographics and evolving clinical management …

Objectives To develop and validate a prediction score, to quantify, within 48 h of
Staphylococcus aureus bacteremia (SAB) diagnosis, the risk of IE, and therefore determine …

Objectives Enterococcal bacteremia can be complicated by infective endocarditis (IE) and
when suspected, transesophageal echocardiography (TEE) should be performed. The …

Background Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases
complicated by infective endocarditis. Clinical prediction scores may select patients with …

Background Staphylococcus aureus bacteremia is a life-threatening condition that may lead
to metastatic infection, including prosthetic joint infection. Methods To assess clinical factors …

Staphylococcus aureus bloodstream infections are associated with a high morbidity and
mortality. Nevertheless, significance of a positive blood culture with this pathogen is often …